Adam Walker’s Pharma Prescribed Podcast

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Steven Thompson is someone who has spent more than two decades reshaping how clinical research actually gets done. He is the Founder of NexTrial.ai, and a leading voice at the intersection of AI, trial activation, and human centred design in healthcare. Across roles at ADM, NuBank, Takeda, and Biogen, Steven built a reputation for transforming complex, slow, legacy processes into streamlined systems that empower the people doing the work. His philosophy is simple but radical: AI shouldn’t replace humans - it should erase the maze that holds them back. At NexTrial.ai, he’s pioneering Trial Activation & Execution Intelligence that delivers zero rejection packets, faster startup, stronger compliance and a future where coordinators, physicians, and teams can operate at their highest capability. Steven brings clarity, courage, and a builder’s mindset to every conversation.

*A warning, that this episode discusses important but potentially difficult topics including suicide, if you are in crisis please seek professional help. I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Amelia Wrighton is the Co-Founder and CEO of the charity Suicide & Co. Her commitment to suicide bereavement is rooted in her lived experience, and is a powerful thread running through her work and leadership.  Amelia lost her mum to suicide at the age of 19, a moment that reshaped her life and set her on a path of advocacy, support and systemic change.  Instead of allowing that loss to remain silent, she chose to transform it into action, co‑founding the organisation, Suicide & Co in 2020, dedicated to helping people navigate the complex, often overlooked journey of bereavement by suicide. She has developed services that offer counselling, guidance and a sense of community for those who suddenly find themselves in a world that doesn’t always know how to talk about traumatic grief.  The charity has been transformative in supporting my family's grief journey to recovery, since losing my darling younger sister Naomi to suicide in September 2024 and for that I will be eternally grateful.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Scott Schliebner is a seasoned biopharmaceutical executive with nearly 30 years of experience spanning biotech, CROs, and nonprofit life sciences organizations. He currently serves as CEO and Founder of Assent Biostrategies. Throughout his career, Scott has built and led high‑impact teams across drug development, commercial strategy, and patient‑centric innovation. His leadership includes senior roles such as Chief Commercial Officer for early‑stage biopharma service organizations and Senior Vice President at TFS HealthScience, where he oversaw clinical development services and contributed to corporate strategy and acquisition due diligence. Scott is widely recognized as a patient advocate and strategic thinker who helps biotech companies accelerate their pipelines and design development programs that meaningfully incorporate patient needs.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Helene Quie is a strategic decision‑maker, founder and CEO of Qmed Consulting, a global healthcare consultancy CRO driving medical device innovation. With more than 25 years at the intersection of science, regulation, and commercial strategy, Helene advises start‑ups and established medtech firms, helping leadership teams translate breakthrough ideas into market‑ready products. Her career includes senior operational roles across leading medtech organisations. In 2006 she founded Qmed to bridge innovation and regulation while elevating patient safety and commercial success. Today Qmed supports medtech pioneers across Europe and beyond, guiding clinical investigations, regulatory transitions, evidence generation and organisational transformation.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Sylvain Berthelot is a clinical technology and life sciences professional with deep expertise in clinical systems and the digital ecosystem that supports modern clinical research. Having worked extensively with sponsors, CROs, and clinical teams, he understands how technology can either streamline or complicate the delivery of high‑quality, compliant clinical trials. In 2024, he joined CRScube, a company whose mission aligns with his commitment to simplifying clinical trial execution through intuitive, people‑centred technology. Alongside his work in clinical innovation, Sylvain is an active voice in industry and patient‑centric conversations through podcasting. He hosts Clinical Data Talks, a podcast that explores the challenges, innovations, and real‑world experiences shaping clinical data management and clinical operations. Sylvain also hosts On One Condition, a human‑focused podcast that raises awareness about chronic health conditions by sharing personal stories. Combining technical expertise with a strong human perspective, Sylvain is dedicated to bridging the gap between systems, data, and the people they ultimately serve.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today we’re joined by Dr.Thibault Geoui - host of the acclaimed Tech and Drugs podcast and a driving force at the intersection of biotech innovation and digital transformation. His podcast has become a go-to platform for unpacking the future of pharma, where Thibault brings a rare blend of scientific insight and startup savvy, having worked across R&D, venture strategy, and digital health ecosystems. As Head of Science Analytics at Charles River Laboratories, Dr. Géoui spearheaded the creation of a forward-thinking product and data strategy — leveraging advanced digital solutions to accelerate discovery and keep the organization at the leading edge of the life sciences sector. In his current role as Director of Transformation at Zühlke, he leads the go-to-market strategy for the company’s Pharma Lab Automation offering, aligning engineering excellence with the real-world demands of drug R&D. His work includes translating complex science into actionable insight, and for connecting the dots between technology, regulation, and patient impact.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Jura Lasas is a clinical research leader and biotech consultant specializing in rare disease clinical operations for small biopharma and biotech companies. With over 20 years bridging academia and industry, she's become the operational compass for biotechs navigating their early phase clinical trials.   Her journey began more than 2 decades ago in a newly independent Lithuania, where she stood at an airport with $400 in her pocket and a one-way ticket to America. That calculated risk, leaving everything known for everything possible, became the template for her career: courage mixed with ruthless pragmatism. She holds a PhD in Neurobiology, which shapes how she approaches both science and leadership. Her career spans both CRO and sponsor side leadership, and she has lived and worked across three continents. That global experience gives her a strong understanding of cultural differences in medicine, research, communication, and decision making.  

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today, I’m joined by Sam Usher. His career began by accident. A place at the National Youth Theatre sparked a fascination with performance that quickly evolved into choreography — the power of expression through the body, communicating emotion without words. He trained at Ballet Rambert and at the Northern School of Contemporary Dance in Leeds before moving to Brussels to perform while simultaneously creating his own work through his company, Feed. After twelve years in dance, a planned move to Montreal took an unexpected detour to Devon for the summer — where he picked up a camera and never put it down. Film replaced the stage, leading to his first ITV commission: a ski series focused not on spectacle, but on the individuals and preparation behind elite performance. That project took him to Chamonix and marked the start of a new direction. From mountain couloirs to open water, sailing introduced him to live sport — the closest thing to stage adrenaline. He built a successful production company that ran for fifteen years before the disruption of lockdown forced another reinvention. Chapter three is rooted in wellbeing: Steam Works — a community-led sauna experience designed around connection, ritual and reset, where Sam and I first met on the beach in South Devon, Bigbury-on-sea.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Duncan Kemp is the founder of Saltware Solutions, a software consultancy firm with a mission to empower life science businesses with innovative and reliable solutions that drive efficiency, enhance productivity, and foster growth. With over 20 years leading the development of software for the life sciences industry, Duncan has translated customer requirements to technical concepts with clarity, so incredible ideas are converted into tangible business benefits. His journey began in 1998 during university whilst working at a small startup developing site automation software for phase I trials. Over a period of two decades Duncan navigated several company acquisitions which resulted in leading multiple teams of software engineers across three continents. In January 2024 that all changed when Duncan was restructured out of his role and decided to make the daunting leap into setting up a business. In March 2025 Duncan and I met at the Association of Clinical Data Mgt event in the beautiful city of Prague. We struck up a friendship and after an amusing butt-dial have kept in contact ever since.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Tom Farrand has worked throughout his career at the intersection of AI and the life sciences. First at IBM helping university hospitals to use supercomputers to model 3D heart scans at higher resolutions. Then he joined leading startups and led the roll out of AI infrastructure for Janssen, Medtronic and Exscientia. Now as CEO and Co-founder of Delfa he's building AI agents which automate clinical operations, starting in patient recruitment. His mission is clear: to accelerate access to life‑saving treatments by reimagining how patients connect with trials.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today, I’m joined by Poorya Amini, founder and CEO of Risklick, a Swiss digital health company that’s redefining how clinical trial protocols are designed. Poorya’s journey spans veterinary medicine, a PhD in pharmacology, and hands‑on experience managing cardiology trials at the University of Bern. In 2019, he launched Risklick to tackle one of pharma’s biggest bottlenecks: protocol inefficiency. Risklick’s flagship product, Protocol AI™, draws on a database of over 800,000 clinical trials to cut protocol development time by 50%, reduce amendments by 20%, and shorten implementation by 40%.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Anna Maxwell is a mission-driven founder, pharmacist and entrepreneur dedicated to widening access to medicines and empowering people to take more control of their health. She is the CEO and Founder of Maxwellia, one of the UK’s most ambitious emerging consumer healthcare companies, on a mission to become a Top 50 global challenger brand in self-care. With more than 30 years’ experience in retail pharmacy, consumer healthcare marketing and commercialising over-the-counter (OTC) medicines, Anna specialises in transforming prescription medicines into trusted, pharmacy-ready brands through the highly regulated process of reclassification. By unlocking the untapped value of legacy drugs, Maxwellia is creating the blockbuster OTC medicine brands of the future and reshaping how people manage everyday health.  As a female founder, she has demonstrated what’s possible when purpose and commercial discipline meet relentless ambition

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Matt Veatch is President and COO of Navidence, and a driving force behind the Real World Wednesdays podcast—a weekly forum that’s reshaping how we think about real-world data (RWD) and real-world evidence (RWE). With more than 25 years of experience advising life sciences organizations, Matt brings a rare blend of operational insight and visionary thinking to the table. He’s a board member of the  Decentralized Trials & Research Alliance (DTRA) and is a regular voice at global summits and conferences.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Nives Rombini is a scientist, data strategist, and founder whose career bridges molecular biology, immunology, and advanced analytics. Nives leads Navis Bio, a venture dedicated to harnessing data-driven insights for biomedical innovation. Rombini’s professional journey began with Swisscom, where she honed her skills in data engineering and AI applications before transitioning to the pharmaceutical sector. Fluent in German, Italian, English, and French, Rombini embodies a cosmopolitan perspective that enriches her scientific collaborations. With a foundation in both laboratory research and computational analysis, she is recognized for her ability to connect disciplines, close evidence gaps, and inspire innovation at the intersection of biology and data science.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Alan Salter is a professional whose career spans military service, international business and healthcare leadership. A proud U.S. Navy veteran, Alan served with distinction before transitioning into the private sector, where he established a management consulting company Caravel International Partners, a strategic venture based in Chicago. In addition, Alan is also President of NRP (Nonprofit Resource Partners) which supports companies by providing fractional(temp) staffing on a not-for-profit basis. His time in the Navy instilled a deep sense of discipline, resilience, and global perspective—qualities that continue to shape his approach to leadership and governance. Alan’s journey reflects a rare blend of service and strategy. From navigating the rigors of military life to steering entrepreneurial ventures, he brings a grounded yet visionary lens to the evolving role of pharmacy and healthcare delivery.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today, we’re joined by Maya Zlatanova, a visionary leader in clinical research innovation and host of the podcast Trials with Maya Z, where she explores the future of trials with global experts and patient advocates. As CEO and co-founder of FindMeCure and TrialHub, Maya is on a mission to make clinical trials more accessible, transparent, and patient-centric. Her platforms empower sponsors and CROs to design smarter trials by integrating real-world data, local standard-of-care insights, and feasibility analytics. With many years of experience in clinical trial regulations and patient recruitment, Maya has trained health ministries, pharma teams, and global organizations, including the UN and NHS. Whether through software, storytelling, or systems change, she champions a future where trials are not just efficient—but human-centered, inclusive, and impactful.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Dr. Daniel Fox, CEO of CRPN Central is a leader redefining clinical research through decentralised, patient-first platforms. With a background in medicine, policy, and digital innovation, Dr. Fox is building scalable ecosystems that restore trust and transparency in trials. His work bridges the technical and the human, empowering communities to take part in research that reflects their needs and values. CRPN’s network spans thousands of professionals, and its mission is clear: restore trust, streamline operations, and make trials truly inclusive. From platform design to public health advocacy, Dr. Fox brings clarity to complexity and compassion to clinical strategy.    

A warning, that this episode discusses important but potentially difficult topics including suicide. I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Ryan Parke is a TEDx speaker, award-winning coach, and a leading voice in men’s mental health. He is the author of the book “How to help him – the book for women worried about a man.” After losing a close friend to suicide in 2019, Ryan launched a deep investigation into why traditional approaches often fail men. His evidence-based framework draws from many hundreds of sources and challenges outdated views on testosterone, showing it’s not a driver of aggression but a vital hormone for calm, resilience, and heart health. Ryan’s 90-day coaching program helps men overcome depression, beat procrastination, and reclaim their purpose. He’s worked with NHS Trusts, international schools, emergency services and is certified in Mental Health First Aid and Suicide First Aid. For full disclosure, I have been working with Ryan for more than a year during one of the most difficult periods of my life – his guidance has been instructive, motivational and transformative both personally and professionally.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Wendy Turenne, widely known in the industry as “Real World Wendy,” is a strategic force in real-world data and evidence generation. Most recently, she served as Senior Vice President of Real World Data and Delivery Operations at Aetion, where she led global teams in transforming RWD into regulatory-grade evidence for pharma, biotech, and health authorities. Prior to Aetion, Wendy held other pivotal roles at Evolent Health, Alere, and Children’s National Hospital, where she built analytics capabilities, scaled delivery operations, and advanced population health initiatives. Her career spans over 20 years across providers, payers, health tech, and government sectors—giving her a uniquely holistic view of the healthcare data ecosystem. Now an independent consultant, Wendy advises life sciences companies on data maturity, evidence strategy, and operational readiness. Whether guiding regulatory strategy or optimizing delivery models, Wendy continues to be a trusted voice in the evolving landscape of data-driven healthcare.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today, we’re joined by Jan Krikava, co-founder and managing director of Docuply—a document automation platform purpose-built for the pharmaceutical and healthcare sectors. With a degree in software engineering and a background in enterprise IT, he’s spent over a decade optimizing digital workflows for regulated industries. Before launching Docuply, Jan led product and strategy teams across Europe, helping life sciences organizations modernize their compliance infrastructure without compromising security or speed. In an industry where compliance isn’t optional and audits can stall progress, Docuply offers a smarter way forward. Designed for CROs, biotech startups, and pharma service providers, Docuply delivers a fully compliant pre-validated electronic quality management system (eQMS) Jan’s vision is clear: simplify quality workflows, reduce audit risk, and empower teams to focus on innovation.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Dr. Andrée Bates is a pioneering force in pharmaceutical AI, known for transforming how life sciences companies harness data to drive growth, innovation, and patient outcomes. As Founder and CEO of Eularis, Dr. Bates has spent over two decades helping top-tier pharma and biotech firms solve complex commercial challenges using artificial intelligence. With a PhD in Neuroscience and Cognitive Science, and a career that began in medical writing and digital transformation, she’s long been at the forefront of healthcare innovation. Dr. Bates lectures in MBA programs on health innovation and AI, and contributing thought leadership, her work reflecting a rare blend of scientific rigor, commercial insight, and visionary thinking.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Paul McCormack, founder of in10tion Performance, whose journey from alcohol-fuelled routines to intentional, alcohol-free living has sparked a movement in personal transformation. After just 30 days without alcohol, Paul experienced such a profound shift in clarity, energy, and purpose that he never looked back. Now, he coaches others to unlock their full potential—without the booze. In the UK, over 20% of adults report drinking more than the recommended weekly limit of 14 units. Alcohol is linked to over 60 medical conditions, including high blood pressure, depression, and cancer. Yet, just one month alcohol-free can lead to a 40% drop in liver fat, improved sleep, and better concentration. Whether you're in pharma, coaching, or simply curious about the ripple effects of alcohol-free living, I hope this episode will offer insight, inspiration, and a fresh perspective on what it means to thrive.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Sverre Bengtsson is a trailblazer in clinical trial innovation and digital transformation. As Co Founder at Viedoc Technologies, he has helped shape one of the most widely adopted eClinical platforms in the world, streamlining trials across more than 80 countries and empowering thousands of research teams to work smarter and faster. He serves as an active Board Member of ACDM (Association for Clinical Data Management). reflecting a deep commitment to advancing data integrity and operational excellence across clinical research. With over three decades of experience, Sverre is also an active angel investor, backing more than 30 life science ventures across Europe.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?   Nuria Coll Bastus is an industry disruptor whose roots in academic research and oncogenomics have blossomed into a bold new vision for clinical trials. Born in Spain and now based in the UK, Nuria brings a cross-cultural lens to one of pharma’s most persistent challenges: patient recruitment. With over 12 years in drug development and a background in oncogenomics (Nuria holds an MBA that served as the launchpad for Clinical Net—a health-tech startup she founded to match patients with trials in under five minutes. Globally, 80% of clinical trials are delayed due to recruitment issues, costing billions annually. Nuria’s platform is changing that—automating access, centralizing data, and empowering both patients and practitioners.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Artem Adrianov. 🎙️ Spotlight: Dr. Artem Andrianov Mathematician. Strategist. Risk based quality mgt trailblazer. As co-founder and CEO of Cyntegrity, Dr. Artem Andrianov has spent over 25 years transforming clinical trials through data intelligence and risk-based methodologies. With a Ph.D. in Mathematical Modelling and an Executive MBA from Cass Business School, Artem blends scientific rigor with business acumen to make trials safer, smarter, and more efficient. Since launching Cyntegrity in 2013, he has led the development of platforms that optimize trial oversight, reduce monitoring costs, and elevate data quality. His work spans collaborations with big Pharma, and his expertise covers Spirometry, ECG, Oncology, ePROs, and centralized monitoring. A speaker and educator, Artem has presented at numerous global conferences, and co-authored the definitive guide to RBQM for clinical researchers. His company’s training arm, MyRBQM Academy, has educated over 1500 professionals from 400+ organizations, setting the standard for RBQM implementation worldwide. Whether modelling risk or mentoring the next generation of trial leaders, Artem is reshaping how the industry thinks about quality, reliability, and patient safety.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Anna Titkova is the International Operations Director at Pratia, one of Europe’s largest site networks, where she oversees operations across multiple countries with a focus on accessibility, innovation, and quality. Born and raised in Ukraine, Anna’s journey is marked not only by professional excellence but by personal courage. Leading a pan-European organization while her homeland faces the ongoing realities of war, she brings a unique perspective on what it means to build systems that endure—and to center compassion in every decision. Under Anna’s leadership, Pratia continues to expand its reach, integrating digital tools and local expertise to make clinical trials more inclusive and responsive to real-world needs.

“I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.” “In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?” Natalie Douglas is a transformative leader whose influence spans global pharma, biotech, and health tech. With over 25 years of board-level experience, Natalie has held CEO roles at Healthcare at Home and Health Outcomes Sciences, and led strategic growth at IDIS (now Clinigen). At Healthcare at Home, she oversaw one of Europe’s largest providers of complex clinical services outside the hospital setting, delivering care to over 150,000 patients annually and redefining how treatment reaches people where they live. Her accolades include: 🏆 PharmaVoice Top 100 💼 Health Investor Power Top 50 🌟 Ernst & Young Entrepreneur of the Year Finalist 🚀 Sunday Times Fast Track (Top Track, Buyout Track, Profit Track) Whether mentoring founders, entrepreneurs and new entrants to the industry or investing in scalable platforms, Natalie brings clarity to complexity—and a social conscience to strategy.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?  Dr. Keith Berelowitz is the founder and CEO of PRX engage a platform designed to revolutionize how we engage and retain patients in clinical trials with over 20 years of experience in pharma and biotech research. Keith blends proven methodologies and AI powered solutions to tackle one of the industry's most pertinent challenges, keeping patients at the heart of research. Before launching pRxEngage, Keith founded Patient Rx Limited, a consultancy founded on tech enabled trial optimization. He also served as operations and commercials director at Richmond Pharmacology. Where his leadership contributed to significant revenue growth and global recognition, his strategic acumen extends beyond business. He currently chairs the Fulham Research Ethics Committee and has advised groups like the CRO Early Phase Working Group and the CCRA executive committee. What sets Keith apart isn't just his resume, it's his relentless focus on ethical, effective, and human centered research. His platform is built to support multi-stakeholder collaboration, to personalize engagement, and to improve retention across diverse populations. In an era where up to 30% of patients drop out of clinical trials, Keith's work is more than innovation, it's intervention.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Steve Sanghera is the CEO of Inventus, a UK-based innovator redefining how clinical trials are powered through secure, provisioned mobile devices. With a background steeped in digital transformation, Steve leads Inventus in delivering smartphones and tablets purpose-built for life sciences—ensuring compliance, data integrity, and patient-centric design. Under his leadership, Inventus has partnered with global tech leaders to simplify the complexities of device provisioning, making clinical research more agile, secure, and scalable.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Board certified internist, national speaker and host of the Lunch and Learn Podcast, which has surpassed 400 episodes and reached thousands of listeners worldwide. Today’s guest is Dr. Berry Pierre - with over 15 years of clinical experience, Dr. Pierre has treated patients across hospitals, rehab centers, and nursing homes, tackling everything from infectious diseases to chronic conditions like hypertension and coronary artery disease. But Dr. Pierre’s impact goes far beyond the clinic. He’s built a digital health ecosystem that includes blogs, vlogs, and educational series like Empower Yourself For Better Health, designed to demystify medicine and empower communities. His YouTube channel alone hosts over 2,000 videos, covering everything from vaccine hesitancy to the intersection of pop culture and public health. In this episode, we explore how Dr. Pierre uses storytelling to bridge the trust gap in healthcare—especially for underserved populations. We’ll discuss his advocacy for inclusive research, his insights on chronic disease management, and the power of transparency in clinical communication. Dr. Pierre doesn’t just inform—he inspires. Whether he’s breaking down complex medical topics or challenging systemic inequities, his voice is reshaping how we think about health, one conversation at a time.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Leigh Fell—a trailblazer in clinical research, a champion of corporate wellbeing, and the visionary founder of Caritas Science Solutions. Leigh’s journey from managing oncology trials to building a purpose-driven CRO is a masterclass in blending scientific rigor with human-centered leadership. With a degree in Physiology, Sport Science & Nutrition from the University of Glasgow, Leigh began her career running clinical trials for cancer therapies. In 2017, she launched Caritas with a bold mission: to create a company that not only advances medicine but also nurtures its people. Today, Caritas specializes in trials for brain disorders and oncology, partnering with pharma innovators to address areas of profound unmet need. Leigh’s leadership philosophy—what she calls corporate athleticism—has led to a 30% increase in employee retention and a culture where wellness and performance go hand in hand. That ethos earned her a place in The Sunday Times feature on “25 Women Succeeding in 2025”—a spotlight on visionary leaders shaping the future of business, science, and society with purpose and resilience. But Leigh’s impact goes beyond metrics. She’s redefining what it means to lead in life sciences: integrating yoga, marathon training, and mindfulness into the rhythm of business. Her belief? That building a company is like training for endurance—requiring discipline, resilience, and heart.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Anders Mortin is a seasoned eClinical professional with over two decades of experience in Clinical Development processes and systems. Known for his strategic vision and leadership, Anders excels in managing cross-functional teams and driving innovative solutions. As a co-founder of the Copenhagen-based pharma consulting firm, TriTiCon, established in 2015, he has been instrumental in shaping the company's success. Anders holds a Master's degree in Engineering Physics from Lund University in Sweden and has been a key player in the industry since the early 90’s. His extensive background in business, data, and project management has provided a solid foundation for TriTiCon's diverse services.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Belma Alispahic, Co-Founder and Chief Scientific Officer of AnalysisMode. With a Master’s in Applied Biotechnology from Uppsala University and a track record of turning complexity into clarity, Belma is reshaping how we think about bioprocess development. At AnalysisMode, she leads the charge behind SimCell, an AI-powered platform designed to accelerate bioprocess efficiency, reduce time-to-market, and future-proof pharmaceutical workflows. Belma recently took the stage at the 9th Bioproduction Congress (BIOPC 2024) in France, where she shared her insights on “Future-Proofing with AI-Powered Bioprocess Development.” Her message was clear: AI isn’t optional—it’s essential for navigating the increasingly complex biopharma landscape. This isn’t just about algorithms—it’s about empowering scientists to make smarter decisions, faster. Belma’s work is a testament to what happens when deep scientific expertise meets bold technological vision.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? At the helm of Delve Health, Wessam Sonbol is driving a revolution in decentralized and hybrid clinical trials. His platform supports studies in over 65 languages, enabling inclusive research across continents. By integrating wearables, TeleVisits, and AI-driven tools, Delve Health has helped sponsors reduce patient dropout rates by up to 30% and accelerate trial timelines by 20%. Wessam’s leadership spans more than 25 years in clinical research and healthcare technology. He’s managed complex Phase I–IV and 510(k) trials for global giants like Medtronic, Abbott Vascular, and Johnson & Johnson. His entrepreneurial journey includes founding Clinical Systems Consultants—scaling it across three continents—and developing platforms that achieved multi-million dollar exits. Inspired by personal experience, Wessam is fiercely committed to patient-centricity. His innovations simplify trial access and elevate outcomes. He also co-developed Perta.io, a data mining platform that connects clinical trials, publications, and drug pipelines using AI and NLP—cutting research time by up to 40% for scientists and sponsors. Whether it’s through founding companies or building ecosystems, Wessam doesn’t just follow the pulse of clinical research. He shapes it.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? In this episode, we sit down with Philip Morisky, Chief Optimus at Adherence, to explore the missing metric in healthcare: medication adherence. Building on the legacy of the Morisky Medication Adherence Scale (MMAS), Philip shares how he's transforming behavioral diagnostics into actionable insights—bridging the gap between validated measurement and real-world impact. From the evolution of MMAS-8R to the launch of ATLAS™, we unpack how fidelity, training, and data intelligence are reshaping global standards in patient care.

Welcome to the Pharma Prescribed podcast I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research. Today, we have the honour of hosting Yuriy Lebid, the dynamic CEO of Pharmaxi, a leading contract research organization based in Ukraine. Yuriy's journey is nothing short of inspiring. Since the onset of the conflict on February 24, 2022, he has not only persevered but has continued to lead and innovate in the face of adversity. Pharmaxi LLC is a Contract Research Organization (CRO) with a keen focus on the regions of Ukraine and Poland. The organization offers a comprehensive range of services in the realm of clinical trials, with an emphasis on regulatory affairs, clinical monitoring, and data management. Under his supervision, we have developed "OnlineCRF," – an in-house Electronic Data Capture (EDC) system. This powerful tool enables efficient and accurate clinical data collection and trial monitoring. As the leader of Pharmaxi LLC, his personal objective is to establish a solid foundation for organic company growth while fostering a motivating work environment to attract talented and self-driven professionals. Join us as we delve into Yuriy's remarkable story, exploring what drew him to the life sciences industry and how he has navigated the challenges to drive Pharmaxi's success.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.” “In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Charbel Abdo. Born and raised in Lebanon, Charbel brings deep-rooted expertise and a global perspective to the future of pharmaceutical care. A fully qualified pharmacist, he built his clinical foundation in Lebanon and recently earned his MSc in Pharmaceutical Sciences—with distinction—at the University of Greenwich. Now based in the UK, Charbel is actively seeking his first opportunity in clinical research. With a passion for evidence-based practice and an eye for regulatory innovation, he’s ready to bring analytical precision and patient-first thinking to a forward-looking clinical trials team. He blends frontline experience with academic depth and is eager to step into the UK clinical research space, where he can apply scientific background and multicultural insight to make meaningful contributions to patient safety and trial excellence.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Matthew Mace. He is redefining what leadership looks like at the cutting edge of clinical research on multiple fronts. Founder of Study Connect Inc., where he’s on a mission to streamline scientific innovation through faster trials and smarter collaboration. He’s not just building a platform—he’s shaping a movement. You might also know him as the host of the Study Success podcast, where he amplifies bold ideas and practical strategies driving real progress in our industry. And now, as a newly appointed Board Director at Precision Cardiovascular, he’s bringing his deep expertise in cardiac innovation to a company creating the next generation of monitoring tech. Previously, as Co-Founder and CSO at Acorai, Matthew led the largest hemodynamic study in heart failure history, secured FDA Breakthrough Device Designation, and raised over $10 million to bring a novel technology to market. With over 15 years across cardiology, AI, and medtech—plus a knack for turning vision into impact—Matthew brings unmatched perspective, purpose, and drive. He is passionate about new technologies and exploring the boundaries to continue the evolution of patient care. His aim is to further enhance the reach of lifesaving technology into the hands of healthcare professionals for the benefit of patients.

Welcome to the Pharma Prescribed podcast. I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research. Today’s guest is Charlotte Chadwick, CEO of Clinology - Making consultants more visible in Pharma and Biotech. The central "why" lies in a commitment to impactful dialogues that highlight collaboration, innovation, and ethical practices.